Connect with us

Business

Pfizer sees robust COVID-19 vaccine demand for years, US$26 billion in 2021 sales

Spread the love

Pfizer on Tuesday (May 4) raised its forecast for 2021 COVID-19 vaccine sales by more than 70 per cent to US$26 billion and said demand from governments around the world fighting to halt the pandemic could contribute to its growth for years to come.

Published

on

41 views